Clinical Trials Directory

Trials / Unknown

UnknownNCT04786782

The vPPG-detecting Software Guided Management of Cirrhotic Portal Hypertension

Clinical Management of Patients With Cirrhotic Portal Hypertension Based on the Noninvasive Portal Pressure Gradient (vPPG) Detecting Software, a Prospective and Controlled Cohort Study

Status
Unknown
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
Changqing Yang · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to investigate the possibilities and effectiveness of managing cirrhotic portal hypertension using the non-invasive portal pressure gradient (PPG) detecting software. In this study, the three-dimensional reconstruction and natural follow-up methods have been respectively applied in the experimental (1st) and active comparator (2nd) group. The virtual PPG is calculated with anatomical and hemodynamic information of portal system collected by ultrasound and CT tests. Cirrhosis patients in the 1st group, with calculated vPPG values, are managed with upper GI endoscopic results. Besides, patients in the 2nd group, are managed according to the most updated Chinese clinical guideline for cirrhotic portal hypertension, namely, patients with either liver stiffness measurement (LSM) \>15kPa or PLT count \<150\*10\^9 should be screened and treated with upper GI endoscopy. The morbidity of decompensated cirrhotic events and mortality of patients in two arms will be compared. The cutoff values of vPPG to spare endoscopies with low missed VNT (varices needing treatment) are preliminarily determined with the cohort data.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPPG-detecting softwareVirtual PPG (vPPG) of patients in experimental group is calculated based on anatomical and hemodynamic information of portal system collected by ultrasound and CT tests.
DIAGNOSTIC_TESTLSM and PLT countPatients whose LSM \>15kPa, or PLT count \< 150\*10\^9 should be screened with upper GI endoscopy

Timeline

Start date
2021-03-03
Primary completion
2023-09-30
Completion
2023-09-30
First posted
2021-03-08
Last updated
2023-04-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04786782. Inclusion in this directory is not an endorsement.